Why is Remus Pharma. falling/rising?

As of 16-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 819.35, which reflects a decrease of 0.65 or 0.08%. The stock has hit a new 52-week low of Rs. 775 today and has underperformed its sector by 0.36%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also seen a significant drop in investor participation, with delivery volume falling by 31.19% compared to the 5-day average. Over the past week, the stock has decreased by 1.03%, and it has a year-to-date decline of 34.39%, highlighting its ongoing struggles in the market.
In the broader market context, the Sensex has shown a positive return of 1.49% over the past week and a 6.74% increase year-to-date, contrasting sharply with Remus Pharmaceuticals' performance. This disparity suggests that while the overall market is gaining, Remus Pharmaceuticals is lagging significantly behind, contributing to investor concerns. The stock's underperformance relative to the benchmark indicates a lack of confidence among investors, further exacerbated by the recent drop in trading volume and the stock's movement below key moving averages.